article thumbnail

Proposed FDA rule targets asbestos in talc cosmetic products

Medical Xpress

Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing cosmetics for asbestos, a known carcinogen linked to serious illnesses such as lung and ovarian cancers.

article thumbnail

Opinion: Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics

STAT News

Congress is considering two measures that modernize tools the Food and Drug Administration uses to oversee two areas of its vast portfolio: diagnostic tests and cosmetics. While the stakes are different for each of these industries, the basic premise driving these measures is the same. Read the rest…

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conference Notebook: ACI’s Cosmetics and Personal Care Products Conference

FDA Law Blog

As readers of our blog know, MoCRA was a significant change to regulation of cosmetics. As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.

article thumbnail

ACI’s Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products – West Coast Edition

FDA Law Blog

The American Conference Institute (“ACI”) is holding its 2nd West Coast Editionof its Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products from September 25-26 at the Le Meridien Delfina, Santa Monica, California. s John W.M. s John W.M. s John W.M.

article thumbnail

Cosmetic and consumer product formulation design: Automation, AI and machine learning webinar

Scienmag

Due to the global pandemic we have re-scheduled the in person Advances in Cosmetic Formulation Design II Conference to Summer 2022.

article thumbnail

Exosomes in Cosmetics

Pharma Tutor

Exosomes in Cosmetics admin Fri, 03/07/2025 - 16:08 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Bengaluru Email : formulation_krc@kopresearchcentre.net

article thumbnail

FDA Designations for Rare Disease Products, Part 1

Camargo

The US FDA offers sponsors a variety of special designation programs to incentivize them to develop and deliver therapies to treat unmet patient needs, such as Fast Track Designation (FTD), Breakthrough Therapy Designation , and Qualified Infectious Disease Product Designation. What type of products qualify? 21 CFR §814 Subpart H.